Oxyglobin

RSS

Haemoglobin glutamer-200 (bovine)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 20/10/2020

Authorisation details

Product details
Name
Oxyglobin
Agency product number
EMEA/V/C/000045
Active substance
haemoglobin glutamer-200 (bovine)
International non-proprietary name (INN) or common name
Haemoglobin glutamer-200 (bovine)
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QB05AA10
Publication details
Marketing-authorisation holder
OPK Biotech Netherlands BV
Revision
16
Date of issue of marketing authorisation valid throughout the European Union
29/11/1999
Contact address

Herikerbergweg 88
1101CM Amsterdam
The Netherlands

Product information

16/10/2020 Oxyglobin - EMEA/V/C/000045 - IAIN/0025/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

Therapeutic indication

Oxyglobin provides oxygen carrying support to dogs improving the clinical signs of anaemia for at least 24 hours, independent of the underlying condition.

Assessment history

How useful was this page?

Add your rating
Average
2 ratings